112 related articles for article (PubMed ID: 16723295)
1. Pulmonary flow reserve in children with idiopathic pulmonary arterial hypertension: implications for diagnosis and therapy.
Zimmermann R; Kreuder J; Michel-Behnke I; Voelkel NF; Schranz D
Eur J Med Res; 2006 May; 11(5):208-13. PubMed ID: 16723295
[TBL] [Abstract][Full Text] [Related]
2. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension.
Onen ZP; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G
Tuberk Toraks; 2006; 54(2):177-81. PubMed ID: 16924576
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
4. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
[TBL] [Abstract][Full Text] [Related]
5. Assessment of pulmonary endothelial function during invasive testing in children and adolescents with idiopathic pulmonary arterial hypertension.
Apitz C; Zimmermann R; Kreuder J; Jux C; Latus H; Pons-Kühnemann J; Kock I; Bride P; Kreymborg KG; Michel-Behnke I; Schranz D
J Am Coll Cardiol; 2012 Jul; 60(2):157-64. PubMed ID: 22766343
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in children with idiopathic pulmonary arterial hypertension.
Yung D; Widlitz AC; Rosenzweig EB; Kerstein D; Maislin G; Barst RJ
Circulation; 2004 Aug; 110(6):660-5. PubMed ID: 15289375
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
Chau EM; Fan KY; Chow WH
Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
[TBL] [Abstract][Full Text] [Related]
9. Impaired release of bioactive parathyroid hormone-related peptide in patients with pulmonary hypertension and endothelial dysfunction.
Sokolova J; Zimmermann R; Kreuder J; Michel-Behnke I; Schranz D; Piper HM; Schluter KD
J Vasc Res; 2007; 44(1):67-74. PubMed ID: 17191022
[TBL] [Abstract][Full Text] [Related]
10. Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy.
Keller RL; Moore P; Teitel D; Hawgood S; McQuitty J; Fineman JR
Pediatr Crit Care Med; 2006 Nov; 7(6):589-94. PubMed ID: 17006391
[TBL] [Abstract][Full Text] [Related]
11. [Combination therapy for the treatment of pulmonary arterial hypertension].
Kähler CM
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S181-2. PubMed ID: 19718614
[No Abstract] [Full Text] [Related]
12. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R
Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of inhaled and intravenous sildenafil in the prevention of the pulmonary endothelial dysfunction due to cardiopulmonary bypass.
Aubin MC; Laurendeau S; Mommerot A; Lamarche Y; Denault A; Carrier M; Perrault LP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):11-7. PubMed ID: 18209563
[TBL] [Abstract][Full Text] [Related]
14. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
[TBL] [Abstract][Full Text] [Related]
17. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
Opitz CF; Wensel R; Winkler J; Halank M; Bruch L; Kleber FX; Höffken G; Anker SD; Negassa A; Felix SB; Hetzer R; Ewert R
Eur Heart J; 2005 Sep; 26(18):1895-902. PubMed ID: 15888496
[TBL] [Abstract][Full Text] [Related]
19. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.
Reichenberger F; Mainwood A; Doughty N; Fineberg A; Morrell NW; Pepke-Zaba J
Respir Med; 2007 Feb; 101(2):217-22. PubMed ID: 16831539
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
Noori S; Friedlich P; Wong P; Garingo A; Seri I
Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
